475 related articles for article (PubMed ID: 9010020)
1. Effect of glucose transport inhibitors on vincristine efflux in multidrug-resistant murine erythroleukaemia cells overexpressing the multidrug resistance-associated protein (MRP) and two glucose transport proteins, GLUT1 and GLUT3.
Martell RL; Slapak CA; Levy SB
Br J Cancer; 1997; 75(2):161-8. PubMed ID: 9010020
[TBL] [Abstract][Full Text] [Related]
2. Increased efflux of vincristine, but not of daunorubicin, associated with the murine multidrug resistance protein (MRP).
Slapak CA; Martell RL; Terashima M; Levy SB
Biochem Pharmacol; 1996 Nov; 52(10):1569-76. PubMed ID: 8937472
[TBL] [Abstract][Full Text] [Related]
3. A possible role for a mammalian facilitative hexose transporter in the development of resistance to drugs.
Vera JC; Castillo GR; Rosen OM
Mol Cell Biol; 1991 Jul; 11(7):3407-18. PubMed ID: 1675425
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein.
Draper MP; Martell RL; Levy SB
Br J Cancer; 1997; 75(6):810-5. PubMed ID: 9062400
[TBL] [Abstract][Full Text] [Related]
6. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells.
Chiang CD; Song EJ; Yang VC; Chao CC
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):759-64. PubMed ID: 7914401
[TBL] [Abstract][Full Text] [Related]
7. Unique mechanism of GLUT3 glucose transporter regulation by prolonged energy demand: increased protein half-life.
Khayat ZA; McCall AL; Klip A
Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):713-8. PubMed ID: 9677332
[TBL] [Abstract][Full Text] [Related]
8. Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells.
Lopes EC; Scolnik M; Alvarez E; Hajos SE
Leuk Res; 2001 Jan; 25(1):85-93. PubMed ID: 11137565
[TBL] [Abstract][Full Text] [Related]
9. Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid.
Rumsey SC; Kwon O; Xu GW; Burant CF; Simpson I; Levine M
J Biol Chem; 1997 Jul; 272(30):18982-9. PubMed ID: 9228080
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
[TBL] [Abstract][Full Text] [Related]
11. Daunorubicin efflux against a concentration gradient in non-P-glycoprotein multidrug-resistant lung-cancer cells.
Mülder HS; Lankelma J; Dekker H; Broxterman HJ; Pinedo HM
Int J Cancer; 1994 Oct; 59(2):275-81. PubMed ID: 7927929
[TBL] [Abstract][Full Text] [Related]
12. Effect of MDR antagonists on the cidal activity of vincristine for cells expressing MDR-1 is superior to those expressing MRP.
Hosoi E; Hirose M; Hamano S; Morimoto M; Kuroda Y
Int J Oncol; 1998 Aug; 13(2):343-8. PubMed ID: 9664131
[TBL] [Abstract][Full Text] [Related]
13. Overcoming of multidrug resistance by introducing the apoptosis gene, bcl-Xs, into MRP-overexpressing drug resistant cells.
Ohi Y; Kim R; Toge T
Int J Oncol; 2000 May; 16(5):959-69. PubMed ID: 10762632
[TBL] [Abstract][Full Text] [Related]
14. Active efflux of the free acid form of the fluorescent dye 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein in multidrug-resistance-protein-overexpressing murine and human leukemia cells.
Draper MP; Martell RL; Levy SB
Eur J Biochem; 1997 Jan; 243(1-2):219-24. PubMed ID: 9030742
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.
Cole SP; Sparks KE; Fraser K; Loe DW; Grant CE; Wilson GM; Deeley RG
Cancer Res; 1994 Nov; 54(22):5902-10. PubMed ID: 7954421
[TBL] [Abstract][Full Text] [Related]
16. Increased sensitivity to vincristine of MDR cells by the leukotriene D4 receptor antagonist, ONO-1078.
Nagayama S; Chen ZS; Kitazono M; Takebayashi Y; Niwa K; Yamada K; Tani A; Haraguchi M; Sumizawa T; Furukawa T; Aikou T; Akiyama S
Cancer Lett; 1998 Aug; 130(1-2):175-82. PubMed ID: 9751271
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductase.
Rappa G; Lorico A; Liu MC; Kruh GD; Cory AH; Cory JG; Sartorelli AC
Biochem Pharmacol; 1997 Sep; 54(6):649-55. PubMed ID: 9310341
[TBL] [Abstract][Full Text] [Related]
18. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
[TBL] [Abstract][Full Text] [Related]
19. Expression of glucose transporters in human peritoneal mesothelial cells.
Schröppel B; Fischereder M; Wiese P; Segerer S; Huber S; Kretzler M; Heiss P; Sitter T; Schlöndorff D
Kidney Int; 1998 May; 53(5):1278-87. PubMed ID: 9573543
[TBL] [Abstract][Full Text] [Related]
20. Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P.
Chuman Y; Chen ZS; Seto K; Sumizawa T; Furukawa T; Tani A; Haraguchi M; Niwa K; Yamada K; Aikou T; Akiyama S
Cancer Lett; 1998 Jul; 129(1):69-76. PubMed ID: 9714337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
